I couldn't agree with you more regarding atenolol! As you mentioned, in younger patients with low risk of AKI (and thus drug accumulation), they usually don't have a compelling indication for atenolol (ie, lone hypertension without comorbidities). In those with true indications for a beta blocker, they often have other risk factors for renal dysfunction that make atenolol a poor selection.
I just found your blog this morning -- very impressive! As a fellow pharmacist, I'm always happy to find professional, evidence-based blogs rather than one complaining about the perils of retail pharmacy. Keep up the good work!
1 comment:
I couldn't agree with you more regarding atenolol! As you mentioned, in younger patients with low risk of AKI (and thus drug accumulation), they usually don't have a compelling indication for atenolol (ie, lone hypertension without comorbidities). In those with true indications for a beta blocker, they often have other risk factors for renal dysfunction that make atenolol a poor selection.
I just found your blog this morning -- very impressive! As a fellow pharmacist, I'm always happy to find professional, evidence-based blogs rather than one complaining about the perils of retail pharmacy. Keep up the good work!
Post a Comment